• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

    7/17/25 4:30:00 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care
    Get the next $OMDA alert in real time by email

    SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2025 results on Thursday, August 7, 2025, after market close, and host a conference call to review the results at 4:30 pm ET the same day.

    Conference Call Details

    Those participating in the conference call can pre-register using the following link: https://register-conf.media-server.com/register/BIce129368a015484a8f39659a48a1631e.

    A live audio webcast of the call will also be available online at https://investors.omadahealth.com. A replay will be available shortly after the conclusion of the call at the same link and will remain accessible for approximately 12 months.

    About Omada Health

    Omada Health is a virtual-first healthcare provider that nurtures lifelong health, one day at a time. Omada care teams implement clinically-validated behavior change protocols for individuals living with diabetes, hypertension, prediabetes, and musculoskeletal issues. With more than a decade of experience and data, and 29 peer-reviewed publications that showcase its clinical and economic results, Omada is designed to help improve health outcomes and contain healthcare costs. Omada's scope exceeds 2,000 customers, including health plans, health systems, and employers ranging in size from small businesses to Fortune 500s.

    The foundation of Omada's success is a strong, vibrant work culture, which helped earn the company the distinction of becoming an officially certified Great Place to Work®. An industry leader, Omada was the first virtual provider to join the Institute for Healthcare Improvement's Leadership Alliance, reflecting the aim to complement primary care providers for the benefit of members, and affirming its guarantee to every partner: Omada works differently.

    Contacts

    Allan Kells

    [email protected]

    Rose Ramseth

    [email protected]



    Primary Logo

    Get the next $OMDA alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OMDA

    DatePrice TargetRatingAnalyst
    7/1/2025$21.00Outperform
    Evercore ISI
    7/1/2025$25.00Overweight
    Morgan Stanley
    7/1/2025$19.00Overweight
    Analyst
    7/1/2025$23.00Buy
    Needham
    7/1/2025$21.00Overweight
    Barclays
    7/1/2025$29.00Buy
    Goldman
    7/1/2025$27.00Buy
    Canaccord Genuity
    More analyst ratings

    $OMDA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Evercore ISI initiated coverage on Omada Health with a new price target

    Evercore ISI initiated coverage of Omada Health with a rating of Outperform and set a new price target of $21.00

    7/1/25 8:41:36 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    Morgan Stanley initiated coverage on Omada Health with a new price target

    Morgan Stanley initiated coverage of Omada Health with a rating of Overweight and set a new price target of $25.00

    7/1/25 8:21:32 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    Analyst initiated coverage on Omada Health with a new price target

    Analyst initiated coverage of Omada Health with a rating of Overweight and set a new price target of $19.00

    7/1/25 8:21:32 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    $OMDA
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Omada Health Inc.

    SCHEDULE 13G - Omada Health, Inc. (0001611115) (Subject)

    8/14/25 4:17:07 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    SEC Form SCHEDULE 13G filed by Omada Health Inc.

    SCHEDULE 13G - Omada Health, Inc. (0001611115) (Subject)

    8/14/25 4:15:16 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    SEC Form 10-Q filed by Omada Health Inc.

    10-Q - Omada Health, Inc. (0001611115) (Filer)

    8/8/25 4:16:56 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    $OMDA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hilleman Jeryl L was granted 376 shares, increasing direct ownership by 4% to 10,112 units (SEC Form 4)

    4 - Omada Health, Inc. (0001611115) (Issuer)

    7/8/25 5:18:11 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    Director Root Jonathan D was granted 237 shares, increasing direct ownership by 2% to 9,973 units (SEC Form 4)

    4 - Omada Health, Inc. (0001611115) (Issuer)

    7/8/25 4:15:30 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    Director Fetter Trevor was granted 257 shares, increasing direct ownership by 3% to 9,993 units (SEC Form 4)

    4 - Omada Health, Inc. (0001611115) (Issuer)

    7/8/25 4:14:24 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    $OMDA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Omada Health Reports Second Quarter 2025 Results

    Revenue of $61 million, up 49%52% Member Growth and Significant Progress Toward Profitability SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) --  Omada Health, Inc. (NASDAQ:OMDA), the virtual between-visit healthcare provider, today reported financial results for the second quarter ended June 30, 2025. 2025 Second Quarter Highlights Total Members of 752,000, up 52% compared to the second quarter of 2024Revenue of $61 million, up 49% compared to the second quarter of 2024GLP-1 Companion Success, with strong growth in members being supported by Omada's GLP-1 companion programs - now available through two of the largest pharmacy benefit managers in the United StatesOmada Horizon Day: In M

    8/7/25 4:05:00 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

    SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2025 results on Thursday, August 7, 2025, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details Those participating in the conference call can pre-register using the following link: https://register-conf.media-server.com/register/BIce129368a015484a8f39659a48a1631e. A live audio webcast of the call will also be available online at https://investors.omadahealth.com. A replay will be available shortly after the conclusion of the call at the same l

    7/17/25 4:30:00 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    Omada Health's Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks

    SAN FRANCISCO, June 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, released new data1 demonstrating that Omada's GLP-1 companion program significantly improved persistence rates for GLP-1 medications. Evidence suggests that persistence on a GLP-1 is associated with greater weight loss.2 Omada's analysis found that those who persisted with their GLP-1 medication achieved weight loss results similar to what has been found in controlled research settings.1 Despite a growing body of evidence supporting vast clinical benefits of GLP-1s,3 while results vary widely, one study showed that one-third of people stopped taking their GLP-1 in

    6/17/25 9:00:00 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    $OMDA
    Leadership Updates

    Live Leadership Updates

    View All

    Omada Health's Enhanced GLP-1 Care Track Demonstrates Increased Medication Persistence and Weight Loss Outcomes at 12 and 24 Weeks

    SAN FRANCISCO, June 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, released new data1 demonstrating that Omada's GLP-1 companion program significantly improved persistence rates for GLP-1 medications. Evidence suggests that persistence on a GLP-1 is associated with greater weight loss.2 Omada's analysis found that those who persisted with their GLP-1 medication achieved weight loss results similar to what has been found in controlled research settings.1 Despite a growing body of evidence supporting vast clinical benefits of GLP-1s,3 while results vary widely, one study showed that one-third of people stopped taking their GLP-1 in

    6/17/25 9:00:00 AM ET
    $OMDA
    Medical/Nursing Services
    Health Care

    $OMDA
    Financials

    Live finance-specific insights

    View All

    Omada Health to Announce Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

    SAN FRANCISCO, July 17, 2025 (GLOBE NEWSWIRE) -- Omada Health (NASDAQ:OMDA), the virtual between-visit healthcare provider, today announced that it will release its second quarter 2025 results on Thursday, August 7, 2025, after market close, and host a conference call to review the results at 4:30 pm ET the same day. Conference Call Details Those participating in the conference call can pre-register using the following link: https://register-conf.media-server.com/register/BIce129368a015484a8f39659a48a1631e. A live audio webcast of the call will also be available online at https://investors.omadahealth.com. A replay will be available shortly after the conclusion of the call at the same l

    7/17/25 4:30:00 PM ET
    $OMDA
    Medical/Nursing Services
    Health Care